Syntostigmin

Neostigmine A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.

Molecular Formula: C₁₃H₂₂N₂O₆S

InChI: InChI=1/C12H19N2O2.CH4O4S/c1-13(2)12(15)16-11-8-6-7-10(9-11)14(3,4)5;1-5-6(2,3)4/h6-9H,1-5H3;1H3,(H,2,3,4)/q+1;/p-1/fC12H19N2O2.CH3O4S/qm;-1

InChIKey: InChIKey=OSZNNLWOYWAHSS-UQMCUWGUCQ
SMILES: CN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C.COS(=O)(=O)[O-]

Names:
    Eustigmin methylsulfate
    Hodostin
    Neostigmeth
    Normastigmin
    Polstigmine
    Proserine
    Prostigmin
    Synstigmine
    Syntostigmin (VAN)
    Syntostigmin
    [3-(dimethylcarbamoyloxy)phenyl]-trimethyl-azanium; sulfonatooxymethane

Registries:
    PubChem CID 5824
    PubChem ID 148616